Earlier this year, drugmaker GSK stopped making the asthma inhaler Flovent (fluticasone)—which was available as a metered-dose inhaler (Flovent HFA) and a dry powder inhaler (Flovent Diskus). Instead, the company opted to produce its own authorized generic version of fluticasone. However, with the manufacturing change, patients are experiencing insurance barriers and delays in getting their prescriptions filled, according to NPR. It’s especially concerning for children under age 5 who may not have many asthma inhaler …
Read More